{"nct_id":"NCT03164967","title":"Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16","status":"COMPLETED","status_verified_date":"2023-01","start_date":"2016-12-29","start_date_type":"ACTUAL","primary_completion_date":"2022-08-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-31","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["ADMA"]}